Strand Therapeutics Inc.
BiotechnologyClinical-stage Biotechnology
Boston, MA
About
Strand Therapeutics is a clinical-stage biotechnology company developing programmable mRNA therapeutics to treat cancer and other life-threatening diseases. Founded by biological engineers from MIT, the company aims to create autonomous medicines that can precisely target diseased cells and deliver multi-functional treatments. The core technology is based on the first mRNA programming language, designed to improve therapeutic outcomes.
Company Values
The company's innovation lies in its intelligent, tumor-targeted mRNA platform that enables the creation of programmable drugs. These drugs can act specifically at the site of disease, which could offer a more precise and effective alternative to systemic treatments.